6 orthobiologics updates
From funding to FDA clearances, here are six key developments in orthopedic regenerative medicine since March 7.
Stay updated with breaking news from Frank Vizesi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
From funding to FDA clearances, here are six key developments in orthopedic regenerative medicine since March 7.
"Discover the latest executive shake-ups in the orthopedic and spine industry, including new appointments and leadership changes in major companies."
12.10.2023 - Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft. Available in both a putty and strip ... Seite 1
Orthofix today announced it received FDA 510(k) clearance for its OsteoCove bioactive synthetic graft.
CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical...